Trial Profile
Prospective, Double-blind, Randomised, Placebo Controlled, Phase III Clinical Study Assessing the Efficacy of Natural Progesterone 25 mg/Bid Administered Subcutaneously in the Maintenance of Early Pregnancy in Women With Symptoms of Threatened Abortion
Status:
Discontinued
Phase of Trial:
Phase III
Latest Information Update: 05 Nov 2021
Price :
$35
*
At a glance
- Drugs Progesterone (Primary)
- Indications Spontaneous abortion
- Focus Therapeutic Use
- Sponsors IBSA
- 18 Jul 2018 Status changed from recruiting to discontinued.
- 07 Jul 2017 Status changed from not yet recruiting to recruiting.
- 11 Nov 2016 New trial record